Company / Profit Margin
AVADEL PHARMACEUTICALS PLC Profit Margin History
FY2015-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Profit Margin
-28.9%
FY2024
5-year range
-28.9% / 31.5%
FY2020-FY2024
Trend
-
vs FY2023
Sector context
#79 of 146
Health Care
What the data says
At -28.9%, AVADEL PHARMACEUTICALS PLC's profit margin ranks #79 of 146 in the Health Care sector. Profit Margin has fluctuated over the past 7 years, ranging from -92.3% in FY2018 to 39.4% in FY2017.
Based on SEC 10-K filings.
-28.9% in FY2024 with a 5-year CAGR of +27.2%.
Improved from -56.1% to -28.9% over the past 5 years.
Health Care sector context is included.
Profit Margin over time
Growth rates
- 3-Year Change
- -
- 5-Year Change
- +27.2pp
- 10-Year Change
- -
Sector benchmark
#79 of 146 in Health CareTop 54% of 146This company -28.9% Sector average -796.3%
▼
+96.4% above sector average
Key checks
Key Insights
- Currently 767.4pp above the Health Care sector average.
- Peak profit margin was recorded in FY2017.
- Lowest profit margin in the period was in FY2018.
Company context
Key Data Points
- Altman Z-Score 0.94 (distress zone, below 1.8 threshold)
- Negative profit margin: -28.9%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Profit MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | -28.9% | - |
| FY2023 | - | - |
| FY2022 | - | - |
| FY2021 | - | - |
| FY2020 | 31.5% | +156.1% |
| FY2019 | -56.1% | +39.2% |
| FY2018 | -92.3% | -334.2% |
| FY2017 | 39.4% | +243.5% |
| FY2016 | -27.5% | -213.7% |
| FY2015 | 24.2% | - |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026